Sponsored Content
Health Policy
Intercell Issues Convertible Bond
The Austrian pharmaceutical company Intercell starts offering of € 30.8m senior convertible debt financing.
February 23, 2011
Sanochemia: Strong Increase in EBIT
The Austrian pharmaceutical company today announced its figures for Q1. Earnings rise eight-fold.
February 18, 2011
Sanochemia Stays in the Red
Despite improvements in its financial data, the Austrian pharmaceutical company Sanochemia does not succeed in eliminating its losses
January 28, 2011
Humanomed to Expand to CEE/SEE
The Austrian Humanomed-Group, a health care company, sees potential to expand to countries in (South) Eastern Europe.
January 28, 2011
Pfizer Austria: First Sustainability Report Published
Pfizer Austria published its first sustainability report based on the recognized guidelines of the Global Reporting Initiative.
January 20, 2011
Sanochemia: Decrease in Sales, Decrease in Losses
The Vienna Stock Exchange listed manufacturer of pharmaceutical products could improve its results slighty.
January 3, 2011
Intercell Raises Authorized Capital
The Management Board of the Austrian biotechnology company is authorized to increase the share capital up to a nominal amount of € 855,000.00.
December 16, 2010
Serious setback for Intercell
The Vienna vaccine manufacturers has to terminate a research project unexpectedly at a late stage. Heavy losses are expected for this year.
December 14, 2010
Economic Chamber in Tokyo: Biotechnology as an Opportunity
The President of the Vienna Economic Chamber, Brigitte Jank, sees above all great opportunities for Austria in Japanese biotechnology and pharmaceutical industries.
December 6, 2010
Expansion Potential of Austrian Pharmaceutical Industry in Japan
Japanese pharmaceutical companies need new products and international cooperation. An opportunity for local companies.
December 1, 2010
Economic Chamber President Leitl Demands Financial Transaction Tax
There is consensus between the Presidents of the Economic Chamber and the Federation of Trade Unions.
November 23, 2010
F-Star Acquired Major Order
The Vienna-located f-star and Boehringer Ingelheim to collaborate in discovery and development of therapeutic antibodies.
November 23, 2010
Roche Lays Off 400 Jobs in Styria
The Swiss pharmaceutical group reduces its international workforce by 6%: a setback for the region.
November 18, 2010
Standard & Poor’s: Austria's Credit Rating at Risk
The reasons for such gloomy prospects are not problems with the banks or domestic companies, but rather the demographic situation threaten Austria's credit rating.
November 11, 2010
Criticism of Austria's Allocation of Subsidies
Both the volume and the organization of the allocation of subsidies are susceptible of improvement, experts say.
October 21, 2010
Humanomed Takes Over Management of Private Clinics in the CEE Region
The know-how of the private clinic operator is to be exported. The objective is not to only give advice, but also to take over the management of private clinics in the CEE region.
September 28, 2010